Laboratory testing on cerebrospinal fluid. A reappraisal

Lancet. 1987 Jan 3;1(8523):1-4. doi: 10.1016/s0140-6736(87)90698-2.

Abstract

555 consecutive cases in which cerebrospinal fluid (CSF) was sent for cell count were reviewed to determine which cerebrospinal-fluid tests affect diagnosis or therapy. Among 334 cases (60%) with a normal opening pressure, cell count, and protein, 1385 additional tests were done, but such tests were useful in only 3 patients (0.9%) with multiple sclerosis. Among 148 consecutive cases of bacterial, chronic infectious, and malignant meningitis the opening pressure, cell count, or protein was abnormal in all but 3 (2 childhood bacterial meningitis and 1 cryptococcal meningitis in a patient with the acquired immunodeficiency syndrome). If the opening pressure, cell count, and protein are normal, no additional CSF tests are needed in most instances; however, in immunocompromised patients and in those with possible multiple sclerosis or childhood bacterial meningitis additional tests may be indicated.

MeSH terms

  • Adolescent
  • Adult
  • Cell Count
  • Cerebrospinal Fluid / analysis
  • Cerebrospinal Fluid / cytology*
  • Cerebrospinal Fluid Proteins / analysis
  • Child, Preschool
  • Chronic Disease
  • Clinical Laboratory Techniques / methods*
  • Clinical Laboratory Techniques / statistics & numerical data
  • Diagnostic Tests, Routine
  • Evaluation Studies as Topic
  • False Positive Reactions
  • Glucose / cerebrospinal fluid
  • Hospital Bed Capacity, 500 and over
  • Humans
  • Infant
  • Intracranial Pressure
  • Meningitis / diagnosis
  • Multiple Sclerosis / cerebrospinal fluid
  • Outcome and Process Assessment, Health Care*
  • Retrospective Studies

Substances

  • Cerebrospinal Fluid Proteins
  • Glucose